Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
מצבים רפואיים
NSCLC (Non-small Cell Lung Cancer) · Non-Small Cell Lung Cancer · NSCLC · NSCLC (Non-small Cell Lung Carcinoma) · NSCLC (Advanced Non-small Cell Lung Cancer)
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Alabama Oncology, Birmingham, Alabama, United States
Contact: Study coordinator (Stephanie (Sherbet) Abercrombie, CRC) · Stephanie.Abercrombie@alabamaoncology.com · 205-803-4369MemorialCare Long Beach Medical Center, Long Beach, California, United States
Yale University, Smillow Cancer Center, New Haven, Connecticut, United States
Florida Cancer Specialists & Research Institute - South, Fort Myers, Florida, United States
Contact: Study coordinator (Martina Bedford) · ResearchProgramManagement@flcancer.com · 727-216-1143BRCR Global, Plantation, Florida, United States
Cancer Care Centers of Breevard, Rockledge, Florida, United States
Florida Cancer Specialists & Research Institute - North, St. Petersburg, Florida, United States
Contact: Study coordinator (Martina Bedford) · ResearchProgramManagement@flcancer.com · 239-274-9930Cleveland Clinic Martin North, Stuart, Florida, United States
Florida Cancer Specialists & Research Institute - East, West Palm Beach, Florida, United States
Contact: Study coordinator (Martina Bedford) · ResearchProgramManagement@flcancer.com · 561-366-4100University Cancer and Blood Center, Athens, Georgia, United States
Piedmont Healthcare, Inc, Atlanta, Georgia, United States
Center for Care and Discovery, Chicago, Illinois, United States
The University of Kansas Cancer Center, Westwood, Kansas, United States
Johns Hopkins University of Medicine, Baltimore, Maryland, United States
Karmanos Cancer Institute, Detroit, Michigan, United States
Henry Ford Health, Detroit, Michigan, United States
Washington University School of Medicine - Siteman Cancer Center, St Louis, Missouri, United States
St. Vincent Frontier Cancer Center, Billings, Montana, United States
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States
John Theurer Cancer Center at Hackensack UMC, Hackensack, New Jersey, United States
Contact: Study coordinator (Oncology Clinical Research Referral Office) · OncologyResearchReferral@hmhn.org · 551-996-1777Morristown Medical Center (MMCORC), Morristown, New Jersey, United States
Roswell Park Cancer Institute, Buffalo, New York, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Montefiore Medical Center, The Bronx, New York, United States
UNC Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, North Carolina, United States
TriHealth Cancer & Blood Institute Research, Cincinnati, Ohio, United States
Taylor Cancer Research Center, Maumee, Ohio, United States
Oncology Associates of Oregon PC, Eugene, Oregon, United States
Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States
Avera Saint Luke's Hospital, Aberdeen, South Dakota, United States
Avera Cancer Institute, Sioux Falls, South Dakota, United States
SCRI Oncology Partners - Tennessee, Nashville, Tennessee, United States
Texas Oncology - South Austin, Austin, Texas, United States
Texas Oncology Dallas, Dallas, Texas, United States
Contact: Study coordinator (Christine Terraciano) · christine.terraciano@usoncology.com · 214-370-1000MD Anderson Cancer Center, Houston, Texas, United States
Texas Oncology - Gulf Coast, The Woodlands, Texas, United States
Utah Cancer Specialists, Salt Lake City, Utah, United States
Huntsman Cancer Institute, Salt Lake City, Utah, United States
Virginia Cancer Specialists, Fairfax, Virginia, United States
Blacktown Medical Oncology Research, Blacktown Hospital, Blacktown, New South Wales, Australia
Blacktown Medical Oncology Research, Blacktown, New South Wales, Australia
Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia
St. George Private Hospital Clinical Trials Unit, Kogarah, New South Wales, Australia
Calvary Mater Newcastle, Waratah, New South Wales, Australia
Mater Misericordiae Limited, South Brisbane, Queensland, Australia
Alfred House, Melbourne, Victoria, Australia
Sir Charles Gairdner Hospital, Perth, Western Australia, Australia
Institut Jules Bordet, Anderlecht, Belgium, Belgium
Contact: Study coordinator (Christelle Swidryk) · Christelle.swidryk@hubruxelles.be · +32 (0) 2 541 32 38Grand Hôpital de Charleroi - Les Viviers, Gilly, Belgium
AZ Groeninge, Kortrijk, Belgium
Contact: Principal Investigator (Sofie Derijcke)UZ Leuven-Campus Gasthuisberg, Leuven, Belgium
AZ Delta, Roeselare, Belgium
Contact: Study coordinator (Melissa Masschelin) · melissa.masschelin@azdelta.be · +32 (0)51 23 72 07CHU Strasbourg - Nouvel Hôpital Civil, Strasbourg, Bas Rhin, France
Contact: Principal Investigator (Celine Mascaux)Hopital Nord - CHU Marseille, Marseille, Bouches-du-Rhône, France
Contact: Principal Investigator (Pascale Tomasini)Institut régional du Cancer de Montpellier, Montpellier, Herault, France
Contact: Principal Investigator (Thomas Quentin)CHU Rennes Hôpital Pontchaillou, Rennes, Ille et Vilaine, France
Contact: Principal Investigator (Herva Lena)CHU de Grenoble - Hôpital Albert Michallon, La Tronche, Isere, France
Contact: Principal Investigator (Denis Moro-Sibilot)CHU Nantes - Hôpital Guillaume et René Laënnec, Saint-Herblain, Loire Atlantique, France
Contact: Principal Investigator (Elvire Pons-Tostivint)Institut de Cancerologie de l Ouest, Saint-Herblain, Loire Atlantique, France
Centre Leon Berard, Léon, Lyon, France
Contact: Principal Investigator (Maurice Perol)Hopital Albert Calmette - CHU Lille, Lille, Nord, France
Contact: Principal Investigator (Alexis Cortot)Hôpital Bichat - Claude Bernard, Paris, Paris, France
Hopital Louis Pradel, Bron, Rhone, France
Centre Hospitalier Intercommunal de Créteil, Créteil, Val de Marne, France
Contact: Principal Investigator (Christos Chouaid)Institut Gustave Roussy, Vaillant, Villejuif, France
CHU Brest - Hôpital Morvan, Brest, France
Contact: Principal Investigator (Gilles Quere)Institut Bergonie, Gironde, France
CHU de Toulouse - Hopital Larrey, Toulouse, France
LKI Lungenfachklinik Immenhausen, Immenhausen, Hesse, Germany
Contact: Principal Investigator (Achim Rittmeyer)Universitaetsklinikum Essen, Essen, North Rhine-Westphalia, Germany
Universitaetsklinikum Carl Gustav Carus TU Dresden, Dresden, Saxony, Germany
Thoraxklinik Heidelberg gGmbH, Baden, Wuerttemberg, Germany
Contact: Study coordinator (Farastuk Bozorgmehr) · farastuk.bozorgmehr@med.uni-heidelberg.de · +4962213968077Klinikum Esslingen GmbH, Baden, Germany
Evangelische Lungenklinik Berlin, Berlin, Germany
Hong Kong United Oncology Centre, Hong Kong, Hong Kong
Queen Mary Hospital, Hong Kong, Hong Kong
The Chinese University of Hong Kong, Shatin, Hong Kong
Cork Univeristy Hospital, Cork, Cork, Ireland
Mater Private Hospital, Dublin, Dublin, Ireland
Contact: Principal Investigator (Jane Sui)University Hospital Limerick, Cork, Limerick, Ireland
Beaumont Hospital Cancer Clinical, Dublin, Ireland
IEO Istituto Europeo di Oncologia, Milan, Milano, Italy
Azienda Socio Sanitaria Territoriale Niguarda, Milan, Milano, Italy
Istituto Clinico Humanitas, Rossano, Milano, Italy
Contact: Principal Investigator (Luca Toschi)Fondazione IRCCS San Gerardo dei Tintori, Monza, Milan, Italy
Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Napoli, Italy
Contact: Principal Investigator (Alessandro Morabito)Azienda Ospedaliero Universitaria Pisana (Presidio di Cisanello), Pisa, Pisa, Italy
Contact: Principal Investigator (Iacopo Petrini)Istituto Nazionale dei Tumori Regina Elena IRCCS, Roma, Roma, Italy
Contact: Principal Investigator (Federico Cappuzzo)Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
Aichi Cancer Center Hospital, Nagoya, Aichi-ken, Japan
Fujita Health University Hospital, Toyoake-shi, Aichi-ken, Japan
National Cancer Center Hospital East, Kashiwa-shi, Chiba, Japan
NHO Himeji Medical Center, Matsuyama, Ehime, Japan
NHO Shikoku Cancer Center, Matsuyama, Ehime, Japan
National Hospital Organization Hokkaido Cancer Center, Sapporo, Hokkaido, Japan
Hyogo Cancer Center, Akashi, Hyōgo, Japan
Kanazawa University Hospital, Kanazawa, Ishikawa-ken, Japan
Kanagawa Cancer Center, Yokohama, Kanagawa, Japan
Tohoku University Hospital, Sendai, Miyagi, Japan
Nara Medical University Hospital, Kashihara-shi, Nara, Japan
Niigata Cancer Center, Niigata, Niigata, Japan
Kansai Medical University Hospital, Hirakata-shi, Osaka, Japan
Kindai University Hospital, Osakasayama-shi, Osaka, Japan
Shizuoka Cancer Center, Nagaizumi-chō, Shizuoka, Japan
National Cancer Center Hospital, Chuo Ku, Tokyo, Japan
Cancer Institute Hospital of JFCR, Koto-Ku, Tokyo, Japan
Wakayama Medical University Hospital, Wakayama, Wakayama, Japan
Amsterdam UMC, Locatie VUMC, Amsterdam, Netherlands, Netherlands
Erasmus Medisch Centrum, Rotterdam, Netherlands, Netherlands
Antoni van Leeuwenhoek, Amsterdam, Netherlands
Maastricht University Medical Center P. Debyelaan 25, Maastricht, Netherlands
Radboudumc, Nijmegen, Netherlands
Auckland City Hospital - Cancer and Blood Research, Grafton, Auckland, New Zealand
INSTYTUT GENETYKI I IMMMUNOLOGII GENIM sp. z o.o., Lublin, Poland
Contact: Principal Investigator (Izabela Chmielewska)Med-Polonia Sp. z o.o., Poznan, Poland
Aidport Sp. z o.o., Skorzewo, Poland
Contact: Principal Investigator (Marcin Bednarek)Pan American Center for Oncology Trials, San Juan, Puerto Rico, Puerto Rico
National University Hospital, Singapore, Singapore, Singapore
Contact: Study coordinator (Haematology-Oncology Research Group (HORG) · horg@nuhs.edu.sg · 6908 2222National Cancer Centre Singapore, Singapore, Singapore
Contact: Study coordinator (National Cancer Centre Singapore) · clinical.trials@nccs.com.sg · +65-6436 8000Icon Cancer Centre, Singapore, Singapore
Contact: Study coordinator (ICON Cancer Centre (Research Singapore Team) · researchsingapore@icon.team · +65-66049919Ajou University Hospital, Gyeonggi-do, Suwon-si, South Korea
Chungbuk National University Hospital, Cheongju-si, South Korea
Chonnam National University Hwasun Hospital, Hwasun, South Korea
Korea University Anam Hospital, Seoul, South Korea
Severance Hospital, Yonsei University Health System, Seoul, South Korea
Samsung Medical Center, Seoul, South Korea
Complejo Hospitalario Universitario A Coruña, A Coruña, A Coruña, Spain
Hospital Universitari Dexeus, Barcelona, Barcelona, Spain
Hospital Universitario La Paz, Fuencarral-El Pardo, Madrid, Spain
Hospital Universitario HM Madrid Sanchinarro, Madrid, Madrid, Spain
Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Universitätsspital Basel, Basel, Switzerland
Contact: Principal Investigator (Benjamin Kasenda)HFR Fribourg/Kantonsspital Fribourg, Fribourg, Switzerland
Contact: Principal Investigator (Alessandra Curioni-Fontecedro)Kantonsspital St. Gallen, Sankt Gallen, Switzerland
Contact: Principal Investigator (Martin Frueh)Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan, Taiwan
National Cheng Kung University Hospital, Tainan, Taiwan, Taiwan
National Taiwan University Hospital, Taipei, Taiwan, Taiwan
Taipei Medical University Hospital, Taipei, Taiwan
Contact: Study coordinator (Chao-Hua Chiu (Lung Patients only) · chaohuachiu@gmail.com · 886- 960303216Chang Gung Medical Foundation Linkou, Taoyuan, Taiwan
Royal Marsden Hospital-London, London, Greater London, United Kingdom
The Clatterbridge Cancer Centre, Liverpool, Merseyside, United Kingdom
Royal Marsden Hospital-Sutton, Sutton, Surrey, United Kingdom
The Christie NHS Foundation Trust, Manchester, United Kingdom